PEXIOVEQ
Live / Allowed — Fifth extension granted (statement of use) (as of 18 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Nov 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97695576
- Mark type
- Word mark
- Filed
- 29 Nov 2022
- Published for opposition
- 17 Oct 2023
- Attorney of record
- Alicia Morris Groos
Goods and services
- Class 005 — Pharmaceuticals: Oncolytic viruses being biopharmaceutical agents for the prevention, diagnosis, and treatment of cancer; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer
- Class 042 — Scientific and technological services: Providing information in the field of medical and scientific research on cancer and biologic pharmaceutical products for the prevention, diagnosis, and treatment of cancer
Owner
- SillaJen, Inc., Seoul, KR
- SillaJen, Inc., Seoul, KR
Prosecution history
- 18 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2026 — SOU EXTENSION 5 GRANTED
- 05 Jun 2026 — SOU EXTENSION 5 FILED
- 17 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 05 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Dec 2025 — SOU EXTENSION 4 GRANTED
- 05 Dec 2025 — SOU EXTENSION 4 FILED
- 05 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 17 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2025 — SOU EXTENSION 3 GRANTED
- 16 May 2025 — SOU EXTENSION 3 FILED
- 16 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Dec 2024 — SOU EXTENSION 2 GRANTED